Clinical trial
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively
NCT01884597 is registered in ClinicalTrials.gov with Hawaii Pacific Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively
- Lead sponsor
- Hawaii Pacific Health
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- November 30, 2010
- Completion date
- August 31, 2014
- Enrollment
- 24 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.